Discrimination between fibrin and fibrinogen by a monoclonal antibody against a synthetic peptide.

AUTOR(ES)

Scheefers-Borchel, U

RESUMO

Circulating soluble fibrin, observed in the blood of patients with ongoing intravascular coagulation, is generated from the plasma protein fibrinogen by the limited proteolytic action of thrombin. We report the production of a monoclonal antibody that discriminates between fibrin and fibrinogen in blood. The synthetic hexapeptide Gly-Pro-Arg-Val-Val-Glu, representing the amino terminus of the alpha chain of human fibrin, was used as immunogen. This hexapeptide is located within the A alpha chain of fibrinogen but becomes the amino terminus of the fibrin alpha chain, after fibrinopeptide A is removed by the action of thrombin, and thus becomes accessible for antibody binding. The monoclonal antibody we have prepared can discriminate between fibrin and fibrinogen and thus can be used in assay systems to quantitate soluble fibrin or, potentially, to image fibrin-rich thrombi.

Documentos Relacionados

• Induction of hepatitis A virus-neutralizing antibody by a virus-specific synthetic peptide.
• Synthetic peptide derivatives that bind to fibrinogen and prevent the polymerization of fibrin monomers
• Synthetic peptide derivatives that bind to fibrinogen and prevent the polymerization of fibrin monomers
• Inhibition of glucosyltransferase activities of Streptococcus mutans by a monoclonal antibody to a subsequence peptide.
• Vasonatrin peptide: a unique synthetic natriuretic and vasorelaxing peptide.